Financial Trading Blog

Top S&P500 Stocks Near 52-Week Highs



With the reopening of the US government, the S&P500 is just shy of all-time highs amid renewed optimism and a resurgence of confidence in the AI space. AMD gave the tech sector a boost on Wednesday after providing a strong outlook. The surge has sent many major names above their 52-week highs, while others still trade below but near the level, suggesting further upside to the technical level and perhaps beyond.

3 S&P500 Stocks Near 52-Week Highs

  • Bank of America (BAC): A price of $54.10 places it ~1% away from its 52-week high of $54.69
  • Alphabet (GOOG): A price of $287.39 places it ~1.4% away from $292.34
  • Eli Lilly (LLY): A price of $1,018.33 places it half a percent from its 52-week high of $1,022.42

Bank of America: Still a Safe Bet?

After the stock closed at an all-time high on Wednesday, traders are looking to see if Bank of America has further upside. As a bank, it's a more defensive play, and it's also a favourite of Warren Buffett, as featured in the top holdings of Berkshire Hathaway. Last week, BAC held its investor day, during which it, aiming for EPS to grow at a rate of 12% per year. However, the presentation didn't impress investors, as its outlook was similar to that of other large US banks. Interestingly, the other banks (JPMorgan, Citigroup, and Morgan Stanley) rate Bank of America a buy. Investors may be setting high expectations, as the bank's shares have risen over 23% this year. The companyr, with earnings growing 31% compared to the same period a year ago.

Of the major US banks, BAC and Wells Fargo are the most exposed to Fed rate decisions and could see further gains if interest rates continue to ease. BAC has been on a campaign to refinance its debt, as interest rates in the US have fallen, with CEO Brian Moynihan continuing to focus on efficiency. The, implying a potential 8.9% upside.

Alphabet Riding the AI Wave

Google parent Alphabet is one of the stocks seeing gains this week after AMD raised its outlook for AI demand. The company recently announced plans to invest $6.5 billion in expanding its data centre infrastructure in Germany and an additional $5.5 billion in Turkey as it continues to build its fastest-growing segment. Moving even further away from its main search engine business, what could have many investors excited is the developments in its robotaxi unit, Waymo. The company is ahead of Tesla in the rollout of its service area, having recently announced that it, as well as plans to expand to Tokyo and London soon.

Alphabet is another stock benefiting from the dovish shift in the Fed outlook, as lower rates would likely increase ad spend. Analysts remain bullish on Google, with none of the 67 calling to sell. The average price target is $309.92, implying a potential 7.9% upside.

Eli Lilly's Most Favoured Status

The drugmaker's stock price has surged by nearly 30% in the past few weeks. The first event in that period driving the prices was its, well above the $5.69 forecast. Sales grew 54% from the year earlier, primarily driven by its obesity drugs. Zepbound sales rose 184%, and Mounjaro's revenue more than doubled. The company also boosted its profit and sales outlook for the year. The second significant event during this period was the, which provided GLP-1 drugs to Medicare and Medicaid beneficiaries at a reduced cost in exchange for increased volume.

Analysts appear bullish on the company's prospects, and it has even received a particular mention from CNBC's Jim Cramer, who pointed toof its star weight-loss drug. He suggested the company could cross the $1 trillion valuation mark. Additionally, the company may decide to conduct a stock split to make its shares more attractive to investors. However, the company's run-up has left it with a PE ratio of 50x, which might make some traders nervous.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 62% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to machibet777-app.com.